<DOC>
	<DOCNO>NCT00776334</DOCNO>
	<brief_summary>The objective study compare relative bioavailability fosinopril sodium 40 mg tablet ( Ranbaxy Laboratories Limited , Lot No . 1238312 ) Monopril® healthy adult subject fasting condition .</brief_summary>
	<brief_title>Bioequivalence Study Fosinopril 40mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>The study conduct open label , balance , randomise , two-treatment , two-period , two-sequence , single-dose , crossover , bioequivalence study Fosinopril formulation compare fosinopril 40mg tablet Ranbaxy Laboratories Monopril® healthy , adult , human , subject fast condition Eligible subject underwent pre-study examination include physical examination , 12-1cad ECG , laboratory test - include hematology , blood chemistry , urinalysis , infectious disease ( Hepatitis B , Hepatitis C , HIV ) , urine drug abuse . Laboratory test female subject also include serum pregnancy test . Forty ( 40 ) subject enrol study ; 39 complete study .</detailed_description>
	<mesh_term>Fosinopril</mesh_term>
	<criteria>Noninstitutionalized subject consist member community large . Characterization Study Group All subject select study least 18 year age . Clinical laboratory measurement include follow : Hematology : hemoglobin , hematocrit , red blood cell count , platelet , white blood cell count ( differential ) . Clinical Chemistry : creatinine , BUN , glucose , SGOT/AST , SGPT/ALT , bilimbin , alkaline phosphatase . Urine Analysis : pH , specific gravity , protein , glucose , ketone , bilimbin , occult blood , cell . HIV Screen : ( prestudy ) HepatitisB , C Screen : ( prestudy ) Drugs Abuse Screen : prestudy checkin study period Subjects history chronic alcohol consumption ( past 2 year ) , drug addiction , serious gastrointestinal , renal , hepatic cardiovascular disease , tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma eligible study . Subjects whose clinical laboratory test value great 20 % outside normal range may retested . If clinical value outside range retesting , subject eligible participate study unless clinical investigator deem result significant . Subjects history allergic response class drug test ( include penicillin product ) exclude study . All subject urine sample assay presence drug abuse part clinical laboratory screening procedure checkin study period . Subjects find urine concentration test drug allow participate . Subjects donate blood and/or plasma least thirty ( 30 ) day prior first dose study . Subjects take investigational drag within thirty ( 30 ) day prior first dose study allow participate . Female subject pregnant able ( woman child bear potential ) become pregnant study allow participate . Female subject child bear potential must either abstain sexual intercourse use reliable barrier method ( eg condom , IUD ) contraception course study ( first dose last blood collection ) allow participate . Subjects use implant injected hormonal contraceptive ( except Lunelle monthly injection ) anytime 6 month prior study dose , Lunelle monthly injection anytime 45days prior study dose use hormonal contraceptive within 14 day dose allowed participate . All female subject screen pregnancy check study period . Subjects positive inconclusive result withdrawn study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>bioequivalence Fosinopril Tablets</keyword>
</DOC>